PharmaTimesNews & Politicsnews

Novartis receives European Commission approval for Itvisma for spinal muscular atrophy

Thursday, July 2, 2026John PinchingView original

EC backs first gene replacement therapy for broad sma population

Read the full article on the original site.

Read Full Article